APO Research

APO RESEARCH · REPORT

Gene Sequencing

Selected research

Market Analysis & Forecast

Global Gene Sequencing Market Analysis and Forecast 2026-2032

Market perspective

The global Gene Sequencing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Gene Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gene Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gene Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gene Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Gene Sequencing include Illumina, Thermo Fisher Scientific, Eurofins Scientific, BGI Genomics, Natera, Berry Genomics, Roche, Novogene and Mgi Tech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Gene Sequencing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gene Sequencing, also provides the revenue of main regions and countries. Of the upcoming market potential for Gene Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gene Sequencing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gene Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Gene Sequencing revenue, projected growth trends, production technology, application and end-user industry.

Gene Sequencing Segment by Company

Illumina

Thermo Fisher Scientific

Eurofins Scientific

BGI Genomics

Natera

Berry Genomics

Roche

Novogene

Mgi Tech

LabCorp

Pacific Biosciences

Azenta Life Sciences

Oxford Nanopore

Macrogen

Gene Sequencing Segment by Type

Next-generation Sequencing

Third and Fourth Generation Sequencing

First-generation Sequencing

Gene Sequencing Segment by Application

Academic Research

Clinical Research

Hospital Clinic

Pharmaceuticals and Biotechnology

Others

Gene Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Gene Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Gene Sequencing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Sequencing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gene Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Next-generation Sequencing Major Player Table 3. Third and Fourth Generation Sequencing Major Player Table 4. First-generation Sequencing Major Player Table 5. Global Gene Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Academic Research Major Player Table 7. Clinical Research Major Player Table 8. Hospital Clinic Major Player Table 9. Pharmaceuticals and Biotechnology Major Player Table 10. Others Major Player Table 11. Gene Sequencing Industry Trends Table 12. Gene Sequencing Industry Drivers Table 13. Gene Sequencing Industry Opportunities and Challenges Table 14. Gene Sequencing Industry Restraints Table 15. Global Gene Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Gene Sequencing Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Gene Sequencing Market Share by Region (2021-2026) Table 18. Global Gene Sequencing Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Gene Sequencing Market Share by Region (2027-2032) Table 20. Global Gene Sequencing Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Gene Sequencing Revenue Market Share by Players (2021-2026) Table 22. Global Gene Sequencing Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Gene Sequencing Key Players Headquarters & Area Served Table 24. Global Gene Sequencing Players, Product Type & Application Table 25. Global Gene Sequencing Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Gene Sequencing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Gene Sequencing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Gene Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Gene Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Gene Sequencing Revenue Market Share by Type (2021-2026) Table 32. Global Gene Sequencing Revenue Market Share by Type (2027-2032) Table 33. Global Gene Sequencing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Gene Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Gene Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Gene Sequencing Revenue Market Share by Application (2021-2026) Table 37. Global Gene Sequencing Revenue Market Share by Application (2027-2032) Table 38. Illumina Company Information Table 39. Illumina Business Overview Table 40. Illumina Gene Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Illumina Gene Sequencing Product Portfolio Table 42. Illumina Recent Development Table 43. Thermo Fisher Scientific Company Information Table 44. Thermo Fisher Scientific Business Overview Table 45. Thermo Fisher Scientific Gene Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Thermo Fisher Scientific Gene Sequencing Product Portfolio Table 47. Thermo Fisher Scientific Recent Development Table 48. Eurofins Scientific Company Information Table 49. Eurofins Scientific Business Overview Table 50. Eurofins Scientific Gene Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Eurofins Scientific Gene Sequencing Product Portfolio Table 52. Eurofins Scientific Recent Development Table 53. BGI Genomics Company Information Table 54. BGI Genomics Business Overview Table 55. BGI Genomics Gene Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. BGI Genomics Gene Sequencing Product Portfolio Table 57. BGI Genomics Recent Development Table 58. Natera Company Information Table 59. Natera Business Overview Table 60. Natera Gene Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Natera Gene Sequencing Product Portfolio Table 62. Natera Recent Development Table 63. Berry Genomics Company Information Table 64. Berry Genomics Business Overview Table 65. Berry Genomics Gene Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Berry Genomics Gene Sequencing Product Portfolio Table 67. Berry Genomics Recent Development Table 68. Roche Company Information Table 69. Roche Business Overview Table 70. Roche Gene Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Roche Gene Sequencing Product Portfolio Table 72. Roche Recent Development Table 73. Novogene Company Information Table 74. Novogene Business Overview Table 75. Novogene Gene Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Novogene Gene Sequencing Product Portfolio Table 77. Novogene Recent Development Table 78. Mgi Tech Company Information Table 79. Mgi Tech Business Overview Table 80. Mgi Tech Gene Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Mgi Tech Gene Sequencing Product Portfolio Table 82. Mgi Tech Recent Development Table 83. LabCorp Company Information Table 84. LabCorp Business Overview Table 85. LabCorp Gene Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. LabCorp Gene Sequencing Product Portfolio Table 87. LabCorp Recent Development Table 88. Pacific Biosciences Company Information Table 89. Pacific Biosciences Business Overview Table 90. Pacific Biosciences Gene Sequencing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Pacific Biosciences Gene Sequencing Product Portfolio Table 92. Pacific Biosciences Recent Development Table 93. Azenta Life Sciences Company Information Table 94. Azenta Life Sciences Business Overview Table 95. Azenta Life Sciences Gene Sequencing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Azenta Life Sciences Gene Sequencing Product Portfolio Table 97. Azenta Life Sciences Recent Development Table 98. Oxford Nanopore Company Information Table 99. Oxford Nanopore Business Overview Table 100. Oxford Nanopore Gene Sequencing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Oxford Nanopore Gene Sequencing Product Portfolio Table 102. Oxford Nanopore Recent Development Table 103. Macrogen Company Information Table 104. Macrogen Business Overview Table 105. Macrogen Gene Sequencing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Macrogen Gene Sequencing Product Portfolio Table 107. Macrogen Recent Development Table 108. North America Gene Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Gene Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Gene Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Gene Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Gene Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. North America Gene Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 114. North America Gene Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 115. Europe Gene Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Gene Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Gene Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Gene Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Gene Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe Gene Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Gene Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 122. China Gene Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 123. China Gene Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 124. China Gene Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 125. China Gene Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 126. Asia Gene Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Gene Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Gene Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 129. Asia Gene Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia Gene Sequencing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Asia Gene Sequencing Revenue by Region (US$ Million) & (2021-2026) Table 132. Asia Gene Sequencing Revenue by Region (US$ Million) & (2027-2032) Table 133. SAMEA Gene Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 134. SAMEA Gene Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 135. SAMEA Gene Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 136. SAMEA Gene Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 137. SAMEA Gene Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. SAMEA Gene Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 139. SAMEA Gene Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Gene Sequencing Image Figure 2. Global Gene Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gene Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Next-generation Sequencing Image Figure 5. Third and Fourth Generation Sequencing Image Figure 6. First-generation Sequencing Image Figure 7. Global Gene Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Gene Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 9. Academic Research Image Figure 10. Clinical Research Image Figure 11. Hospital Clinic Image Figure 12. Pharmaceuticals and Biotechnology Image Figure 13. Others Image Figure 14. Global Gene Sequencing Market Size (US$ Million) & (2021-2032) Figure 15. Global Gene Sequencing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Gene Sequencing Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Gene Sequencing Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Gene Sequencing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Gene Sequencing Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Gene Sequencing Revenue Market Share by Type (2021-2032) Figure 22. Global Gene Sequencing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Gene Sequencing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Gene Sequencing Revenue Market Share by Application (2021-2032) Figure 25. North America Gene Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Gene Sequencing Revenue Share by Type (2021-2032) Figure 27. North America Gene Sequencing Revenue Share by Application (2021-2032) Figure 28. North America Gene Sequencing Revenue Share by Country (2021-2032) Figure 29. United States Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Gene Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Gene Sequencing Revenue Share by Type (2021-2032) Figure 34. Europe Gene Sequencing Revenue Share by Application (2021-2032) Figure 35. Europe Gene Sequencing Revenue Share by Country (2021-2032) Figure 36. Germany Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Gene Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Gene Sequencing Revenue Share by Type (2021-2032) Figure 46. China Gene Sequencing Revenue Share by Application (2021-2032) Figure 47. Asia Gene Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Gene Sequencing Revenue Share by Type (2021-2032) Figure 49. Asia Gene Sequencing Revenue Share by Application (2021-2032) Figure 50. Asia Gene Sequencing Revenue Share by Region (2021-2032) Figure 51. Japan Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Gene Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Gene Sequencing Revenue Share by Type (2021-2032) Figure 59. SAMEA Gene Sequencing Revenue Share by Application (2021-2032) Figure 60. SAMEA Gene Sequencing Revenue Share by Country (2021-2032) Figure 61. Brazil Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Gene Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Next-generation Sequencing
  • Third and Fourth Generation Sequencing
  • First-generation Sequencing
Applications
  • Academic Research
  • Clinical Research
  • Hospital Clinic
  • Pharmaceuticals and Biotechnology
  • Others
Companies covered
  • Illumina
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • BGI Genomics
  • Natera
  • Berry Genomics
  • Roche
  • Novogene
  • Mgi Tech
  • LabCorp
  • Pacific Biosciences
  • Azenta Life Sciences
  • Oxford Nanopore
  • Macrogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gene Sequencing Market by Type
  3. 1.2.1 Global Gene Sequencing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Next-generation Sequencing
  5. 1.2.3 Third and Fourth Generation Sequencing
  6. 1.2.4 First-generation Sequencing
  7. 1.3 Gene Sequencing Market by Application
  8. 1.3.1 Global Gene Sequencing Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Academic Research
  10. 1.3.3 Clinical Research
  11. 1.3.4 Hospital Clinic
  12. 1.3.5 Pharmaceuticals and Biotechnology
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Gene Sequencing Market Dynamics
  1. 2.1 Gene Sequencing Industry Trends
  2. 2.2 Gene Sequencing Industry Drivers
  3. 2.3 Gene Sequencing Industry Opportunities and Challenges
  4. 2.4 Gene Sequencing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Gene Sequencing Market Perspective (2021-2032)
  2. 3.2 Global Gene Sequencing Growth Trends by Region
  3. 3.2.1 Global Gene Sequencing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gene Sequencing Market Size by Region (2021-2026)
  5. 3.2.3 Global Gene Sequencing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Gene Sequencing Revenue by Players
  2. 4.1.1 Global Gene Sequencing Revenue by Players (2021-2026)
  3. 4.1.2 Global Gene Sequencing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Gene Sequencing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gene Sequencing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Gene Sequencing Key Players Headquarters & Area Served
  7. 4.4 Global Gene Sequencing Players, Product Type & Application
  8. 4.5 Global Gene Sequencing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Gene Sequencing Market CR5 and HHI
  11. 4.6.3 2025 Gene Sequencing Tier 1, Tier 2, and Tier 3
5 Gene Sequencing Market Size by Type
  1. 5.1 Global Gene Sequencing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Gene Sequencing Revenue by Type (2021-2032)
  3. 5.3 Global Gene Sequencing Revenue Market Share by Type (2021-2032)
6 Gene Sequencing Market Size by Application
  1. 6.1 Global Gene Sequencing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Gene Sequencing Revenue by Application (2021-2032)
  3. 6.3 Global Gene Sequencing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Illumina
  2. 7.1.1 Illumina Company Information
  3. 7.1.2 Illumina Business Overview
  4. 7.1.3 Illumina Gene Sequencing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Illumina Gene Sequencing Product Portfolio
  6. 7.1.5 Illumina Recent Developments
  7. 7.2 Thermo Fisher Scientific
  8. 7.2.1 Thermo Fisher Scientific Company Information
  9. 7.2.2 Thermo Fisher Scientific Business Overview
  10. 7.2.3 Thermo Fisher Scientific Gene Sequencing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Thermo Fisher Scientific Gene Sequencing Product Portfolio
  12. 7.2.5 Thermo Fisher Scientific Recent Developments
  13. 7.3 Eurofins Scientific
  14. 7.3.1 Eurofins Scientific Company Information
  15. 7.3.2 Eurofins Scientific Business Overview
  16. 7.3.3 Eurofins Scientific Gene Sequencing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Eurofins Scientific Gene Sequencing Product Portfolio
  18. 7.3.5 Eurofins Scientific Recent Developments
  19. 7.4 BGI Genomics
  20. 7.4.1 BGI Genomics Company Information
  21. 7.4.2 BGI Genomics Business Overview
  22. 7.4.3 BGI Genomics Gene Sequencing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 BGI Genomics Gene Sequencing Product Portfolio
  24. 7.4.5 BGI Genomics Recent Developments
  25. 7.5 Natera
  26. 7.5.1 Natera Company Information
  27. 7.5.2 Natera Business Overview
  28. 7.5.3 Natera Gene Sequencing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Natera Gene Sequencing Product Portfolio
  30. 7.5.5 Natera Recent Developments
  31. 7.6 Berry Genomics
  32. 7.6.1 Berry Genomics Company Information
  33. 7.6.2 Berry Genomics Business Overview
  34. 7.6.3 Berry Genomics Gene Sequencing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Berry Genomics Gene Sequencing Product Portfolio
  36. 7.6.5 Berry Genomics Recent Developments
  37. 7.7 Roche
  38. 7.7.1 Roche Company Information
  39. 7.7.2 Roche Business Overview
  40. 7.7.3 Roche Gene Sequencing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Roche Gene Sequencing Product Portfolio
  42. 7.7.5 Roche Recent Developments
  43. 7.8 Novogene
  44. 7.8.1 Novogene Company Information
  45. 7.8.2 Novogene Business Overview
  46. 7.8.3 Novogene Gene Sequencing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Novogene Gene Sequencing Product Portfolio
  48. 7.8.5 Novogene Recent Developments
  49. 7.9 Mgi Tech
  50. 7.9.1 Mgi Tech Company Information
  51. 7.9.2 Mgi Tech Business Overview
  52. 7.9.3 Mgi Tech Gene Sequencing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Mgi Tech Gene Sequencing Product Portfolio
  54. 7.9.5 Mgi Tech Recent Developments
  55. 7.10 LabCorp
  56. 7.10.1 LabCorp Company Information
  57. 7.10.2 LabCorp Business Overview
  58. 7.10.3 LabCorp Gene Sequencing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 LabCorp Gene Sequencing Product Portfolio
  60. 7.10.5 LabCorp Recent Developments
  61. 7.11 Pacific Biosciences
  62. 7.11.1 Pacific Biosciences Company Information
  63. 7.11.2 Pacific Biosciences Business Overview
  64. 7.11.3 Pacific Biosciences Gene Sequencing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Pacific Biosciences Gene Sequencing Product Portfolio
  66. 7.11.5 Pacific Biosciences Recent Developments
  67. 7.12 Azenta Life Sciences
  68. 7.12.1 Azenta Life Sciences Company Information
  69. 7.12.2 Azenta Life Sciences Business Overview
  70. 7.12.3 Azenta Life Sciences Gene Sequencing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Azenta Life Sciences Gene Sequencing Product Portfolio
  72. 7.12.5 Azenta Life Sciences Recent Developments
  73. 7.13 Oxford Nanopore
  74. 7.13.1 Oxford Nanopore Company Information
  75. 7.13.2 Oxford Nanopore Business Overview
  76. 7.13.3 Oxford Nanopore Gene Sequencing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Oxford Nanopore Gene Sequencing Product Portfolio
  78. 7.13.5 Oxford Nanopore Recent Developments
  79. 7.14 Macrogen
  80. 7.14.1 Macrogen Company Information
  81. 7.14.2 Macrogen Business Overview
  82. 7.14.3 Macrogen Gene Sequencing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Macrogen Gene Sequencing Product Portfolio
  84. 7.14.5 Macrogen Recent Developments
8 North America
  1. 8.1 North America Gene Sequencing Revenue (2021-2032)
  2. 8.2 North America Gene Sequencing Revenue by Type (2021-2032)
  3. 8.2.1 North America Gene Sequencing Revenue by Type (2021-2026)
  4. 8.2.2 North America Gene Sequencing Revenue by Type (2027-2032)
  5. 8.3 North America Gene Sequencing Revenue Share by Type (2021-2032)
  6. 8.4 North America Gene Sequencing Revenue by Application (2021-2032)
  7. 8.4.1 North America Gene Sequencing Revenue by Application (2021-2026)
  8. 8.4.2 North America Gene Sequencing Revenue by Application (2027-2032)
  9. 8.5 North America Gene Sequencing Revenue Share by Application (2021-2032)
  10. 8.6 North America Gene Sequencing Revenue by Country
  11. 8.6.1 North America Gene Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Gene Sequencing Revenue by Country (2021-2026)
  13. 8.6.3 North America Gene Sequencing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Gene Sequencing Revenue (2021-2032)
  2. 9.2 Europe Gene Sequencing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Gene Sequencing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Gene Sequencing Revenue by Type (2027-2032)
  5. 9.3 Europe Gene Sequencing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Gene Sequencing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Gene Sequencing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Gene Sequencing Revenue by Application (2027-2032)
  9. 9.5 Europe Gene Sequencing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Gene Sequencing Revenue by Country
  11. 9.6.1 Europe Gene Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Gene Sequencing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Gene Sequencing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Gene Sequencing Revenue (2021-2032)
  2. 10.2 China Gene Sequencing Revenue by Type (2021-2032)
  3. 10.2.1 China Gene Sequencing Revenue by Type (2021-2026)
  4. 10.2.2 China Gene Sequencing Revenue by Type (2027-2032)
  5. 10.3 China Gene Sequencing Revenue Share by Type (2021-2032)
  6. 10.4 China Gene Sequencing Revenue by Application (2021-2032)
  7. 10.4.1 China Gene Sequencing Revenue by Application (2021-2026)
  8. 10.4.2 China Gene Sequencing Revenue by Application (2027-2032)
  9. 10.5 China Gene Sequencing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gene Sequencing Revenue (2021-2032)
  2. 11.2 Asia Gene Sequencing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Gene Sequencing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Gene Sequencing Revenue by Type (2027-2032)
  5. 11.3 Asia Gene Sequencing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Gene Sequencing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Gene Sequencing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Gene Sequencing Revenue by Application (2027-2032)
  9. 11.5 Asia Gene Sequencing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Gene Sequencing Revenue by Country
  11. 11.6.1 Asia Gene Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Gene Sequencing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Gene Sequencing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gene Sequencing Revenue (2021-2032)
  2. 12.2 SAMEA Gene Sequencing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Gene Sequencing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Gene Sequencing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Gene Sequencing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Gene Sequencing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Gene Sequencing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Gene Sequencing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Gene Sequencing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Gene Sequencing Revenue by Country
  11. 12.6.1 SAMEA Gene Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Gene Sequencing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Gene Sequencing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research